Cargando…
The importance of being CAFs (in cancer resistance to targeted therapies)
In the last two decades, clinical oncology has been revolutionized by the advent of targeted drugs. However, the efficacy of these therapies is significantly limited by primary and acquired resistance, that relies not only on cell-autonomous mechanisms but also on tumor microenvironment cues. Cancer...
Autores principales: | Rizzolio, Sabrina, Giordano, Silvia, Corso, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632140/ https://www.ncbi.nlm.nih.gov/pubmed/36324182 http://dx.doi.org/10.1186/s13046-022-02524-w |
Ejemplares similares
-
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells
por: Rizzolio, Sabrina, et al.
Publicado: (2020) -
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
por: De, Pradip, et al.
Publicado: (2022) -
Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021) -
Targeted therapies for gastric cancer: failures and hopes from clinical trials
por: Apicella, Maria, et al.
Publicado: (2017) -
Molecularly Targeted Therapies for Gastric Cancer. State of the Art
por: Reddavid, Rossella, et al.
Publicado: (2021)